Skip to content

A study of treatment of General Fatigue with MSC-CM

The Study of the Treatment for General Fatigue with Human Mesenchymal Stem Cell Conditioned Medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051240097
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-02-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General fatigue Fatigue

Interventions

None listed

Sponsors

Hori Atsushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who did not experience satisfactory effects with standard therapy. 2. Individuals who are determided by the doctor to be appropriate for receive the treatment with the conditioned medium. Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following conditions will be excluded: 1. Users of narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
Medical examination by interview

Secondary

MeasureTime frame
subjective symptoms, etc.

Contacts

Public ContactMasahiro Torii

IGT Clinic

toriim@igtc.jp+81-72-463-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026